1. P862: SERUM MASS SPECTROMETRY TO ANALYZE DISEASE RESPONSE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING ARI0002H, AN ACADEMIC BCMA-DIRECTED CAR T-CELL THERAPY. (23rd June 2022) Authors: Ortiz De Landazuri, I.; Oliver-Caldés, A.; Español-Rego, M.; Contreras, M. T.; Zabaleta, A.; Agulló, C.; Puig, N.; Cabañas, V.; González-Calle, V.; Jiménez, R.; Inogés, S.; Rodríguez-Otero, P.; Martin-Antonio, B.; Reguera, J. L.; López-Diaz de Cerio, A.; Benítez-Ribas, D.; Rodríguez-Lobato, L. G.... Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 755 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. S103: EFFICACY AND SAFETY OF ARI0002H, AN ACADEMIC BCMA-DIRECTED CAR-T CELL THERAPY WITH FRACTIONATED INITIAL THERAPY AND BOOSTER DOSE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA. (23rd June 2022) Authors: Fernandez De Larrea, C.; González-Calle, V.; Oliver-Caldés, A.; Cabañas, V.; Rodríguez-Otero, P.; Español-Rego, M.; Reguera, J. L.; López-Corral, L.; Martin-Antonio, B.; Paiva, B.; Inogés, S.; Rosiñol, L.; López-Díaz de Cerio, A.; Tovar, N.; López-Parra, M.; Rodríguez-Lobato, L. G.; Sánchez-Salin... Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗